Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-05-05 Sale | 2026-05-05 5:02 pm | Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer | 81,953 | $53 | $4,343,509 | 0 (Direct) | View |
| 2026-05-05 Sale | 2026-05-05 5:01 pm | Terns Pharmaceuticals Inc. | TERN | Gengos Andrew Chief Financial Officer | 68,750 | $53 | $3,643,750 | 0 (Direct) | View |
| 2026-05-05 Sale | 2026-05-05 5:00 pm | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 150,000 | $53 | $7,950,000 | 0 (Indirect Direct) | View |
| 2026-04-01 Sale | 2026-04-02 6:15 pm | Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer | 942 | $52.75 | $49,693 | 105,673 (Direct) | View |
| 2026-03-16 Sale | 2026-03-17 6:10 pm | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 14,583 | $46.71 | $681,108 | 1,252,829 (Indirect Direct) | View |
| 2026-02-17 Sale | 2026-02-18 7:01 pm | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 14,583 | $39.19 | $571,579 | 1,267,412 (Indirect Direct) | View |
| 2026-01-15 Sale | 2026-01-16 5:22 pm | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 68,749 | $37.07 | $2,548,603 | 3,607,644 (Indirect Direct) | View |
| 2026-01-05 Sale | 2026-01-06 8:26 pm | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 71,339 | $38.1 | $2,718,230 | 1,200,744 (Indirect Direct) | View |
| 2026-01-02 Sale | 2026-01-06 8:25 pm | Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer | 1,155 | $38.57 | $44,552 | 50,365 (Direct) | View |
| 2025-11-04 Sale | 2025-11-05 6:17 pm | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 24,520 | $18 | $441,360 | 3,955 (Direct) | View |
| 2025-10-01 Sale | 2025-10-02 7:24 pm | Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer | 944 | $7.8464 | $7,407 | 51,520 (Direct) | View |
| 2025-07-01 Sale | 2025-07-03 2:55 pm | Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer | 853 | $4.2671 | $3,640 | 52,464 (Direct) | View |
| 2025-06-27 Purchase | 2025-06-30 5:38 pm | Terns Pharmaceuticals Inc. | TERN | Gengos Andrew Chief Financial Officer | 10,000 | $3.9283 | $39,283 | 25,000 (Direct) | View |
| 2025-06-25 Purchase | 2025-06-25 6:08 pm | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 23,314 | $3.8702 | $90,230 | 47,083 (Direct) | View |
| 2025-06-13 Purchase | 2025-06-16 6:05 pm | Terns Pharmaceuticals Inc. | TERN | Gengos Andrew Chief Financial Officer | 15,000 | $3.8055 | $57,083 | 15,000 (Direct) | View |
| 2025-04-01 Sale | 2025-04-02 6:48 pm | Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer | 952 | $2.4851 | $2,366 | 53,317 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-05 Equity Swap | 2026-05-05 5:02 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer | 24,562 | $53 | 0 (Direct) | View |
| 2026-05-05 Equity Swap | 2026-05-05 5:01 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Gengos Andrew Chief Financial Officer | 40,503 | $53 | 0 (Direct) | View |
| 2026-05-05 Equity Swap | 2026-05-05 5:00 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 154,933 | $53 | 0 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-17 6:10 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 14,583 | $4.64 | 1,252,829 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-17 6:10 pm | N/A 2035-01-29 | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 14,583 | $0 | 1,252,829 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-18 7:01 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 14,583 | $4.64 | 1,267,412 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-18 7:01 pm | N/A 2035-01-29 | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 14,583 | $0 | 1,267,412 (Direct) | View |
| 2026-02-01 Option Award | 2026-02-02 6:07 pm | N/A 2036-01-31 | Terns Pharmaceuticals Inc. | TERN | Turner Heather D Director | 1,697 | $0 | 1,697 (Direct) | View |
| 2026-02-01 Option Award | 2026-02-02 6:07 pm | N/A 2036-01-31 | Terns Pharmaceuticals Inc. | TERN | Tripuraneni Radhika Director | 1,697 | $0 | 1,697 (Direct) | View |
| 2026-02-01 Option Award | 2026-02-02 6:06 pm | N/A 2036-01-31 | Terns Pharmaceuticals Inc. | TERN | Azelby Robert Director | 1,697 | $0 | 1,697 (Direct) | View |
| 2026-02-01 Option Award | 2026-02-02 6:06 pm | N/A 2036-01-31 | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 1,697 | $0 | 1,697 (Direct) | View |
| 2026-02-01 Option Award | 2026-02-02 6:05 pm | N/A 2036-01-31 | Terns Pharmaceuticals Inc. | TERN | KINDLER JEFFREY B Director | 1,697 | $0 | 1,697 (Direct) | View |
| 2026-02-01 Option Award | 2026-02-02 6:05 pm | N/A 2036-01-31 | Terns Pharmaceuticals Inc. | TERN | FELLOWS DAVID A Director | 2,828 | $0 | 2,828 (Direct) | View |
| 2026-01-14 Option Award | 2026-01-16 5:24 pm | N/A 2036-01-13 | Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer | 168,750 | $0 | 219,115 (Direct) | View |
| 2026-01-14 Option Award | 2026-01-16 5:23 pm | N/A 2036-01-13 | Terns Pharmaceuticals Inc. | TERN | Gengos Andrew Chief Financial Officer | 206,250 | $0 | 239,288 (Direct) | View |
| 2026-01-15 Exercise | 2026-01-16 5:22 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 41,666 | $4.64 | 3,607,644 (Direct) | View |
| 2026-01-15 Exercise | 2026-01-16 5:22 pm | N/A 2035-01-29 | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 68,749 | $0 | 3,607,644 (Direct) | View |
| 2026-01-14 Option Award | 2026-01-16 5:22 pm | N/A 2036-01-13 | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 450,000 | $0 | 3,607,644 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-06 8:26 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 21,551 | $4.64 | 1,200,744 (Direct) | View |
| 2026-01-02 Exercise | 2026-01-06 8:26 pm | N/A 2035-01-29 | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 171,551 | $0 | 1,200,744 (Direct) | View |
| 2025-11-04 Exercise | 2025-11-05 6:17 pm | N/A 2030-12-29 | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 24,520 | $0 | 3,955 (Direct) | View |
| 2025-11-04 Exercise | 2025-11-05 6:17 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 24,520 | $9.24 | 3,955 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 5:44 pm | N/A 2035-06-10 | Terns Pharmaceuticals Inc. | TERN | Tripuraneni Radhika Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 5:44 pm | N/A 2035-06-10 | Terns Pharmaceuticals Inc. | TERN | Lu Hongbo Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 5:43 pm | N/A 2035-06-10 | Terns Pharmaceuticals Inc. | TERN | KINDLER JEFFREY B Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 5:43 pm | N/A 2035-06-10 | Terns Pharmaceuticals Inc. | TERN | Turner Heather D Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 5:43 pm | N/A 2035-06-10 | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 5:42 pm | N/A 2035-06-10 | Terns Pharmaceuticals Inc. | TERN | FELLOWS DAVID A Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-02-24 Option Award | 2025-02-25 6:12 pm | N/A 2035-02-23 | Terns Pharmaceuticals Inc. | TERN | Gengos Andrew Chief Financial Officer | 750,000 | $0 | 750,000 (Direct) | View |
| 2025-02-20 Option Award | 2025-02-24 6:05 pm | N/A 2035-02-19 | Terns Pharmaceuticals Inc. | TERN | Azelby Robert Director | 90,000 | $0 | 90,000 (Direct) | View |